Rabbit Polyclonal Cullin 4A/CUL-4A antibody. Suitable for IHC-P, IP, WB and reacts with Mouse, Human samples. Cited in 25 publications. Immunogen corresponding to Synthetic Peptide within Human Cullin-4A.
View Alternative Names
Cullin-4A, CUL-4A, CUL4A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cullin 4A/CUL-4A antibody (AB72548)
IHC image of ab72548 staining in human normal cervix formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with EDTA (pH9, epitope retrieval solution 2) for 20 mins. The section was then incubated with ab72548, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cullin 4A/CUL-4A antibody (AB72548)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma (left) and mouse squamous cell carcinoma (right) tissues labelling Cullin 4A/CUL-4A with ab72548 at 1/1000 (1μg/ml). Detection : DAB.
- WB
Unknown
Western blot - Anti-Cullin 4A/CUL-4A antibody (AB72548)
All lanes:
Western blot - Anti-Cullin 4A/CUL-4A antibody (ab72548) at 0.1 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 5 µg
Lane 4:
293T whole cell lysate at 50 µg
Lane 5:
NIH3T3 whole cell lysate at 50 µg
Predicted band size: 88 kDa
Observed band size: 117 kDa,88 kDa
false
- WB
CiteAb
Western blot - Anti-Cullin 4A/CUL-4A antibody (AB72548)
Western Blotting using Anti-Cullin 4A/CUL-4A antibody, ab72548. Publication image from Lu, H. et al., 2017, Nat Commun, 29229926. Legend direct from paper.
DDB1-CUL4A E3 ubiquitin ligase stimulates RECQL4 recruitment to DSBs. a Co-IP analysis for the interaction of RECQL4 with DDB1 and CUL4A in HEK293T cells. DDB1 and CUL4A were pulled down with 3xFLAG-tagged RECQL4 from HEK293T cells. b N-terminal domain of RECQL4 interacts with DDB1 in HEK293T cells. Upper panel shows schematic diagram of 3xFLAG-tagged RECQL4 and the truncated fragments. N-terminal domain (RQ4-NT), helicase domain (RQ4-HE), and C-terminal domain (RQ4-CT) were tagged with both 3xFLAG and SV40 nuclear-location sequence (NLS). c Knockdown of either DDB1 or CUL4A inhibits ubiquitination of RECQL4 in U2OS cells. Endogenous RECQL4 was purified with anti-RECQL4 antibody from denatured U2OS cell lysates and the ubiquitination was then detected with anti-Ub antibody. d Inhibition of CDK1 and CDK2 reduced the ubiquitination of RECQL4 in U2OS cells. RECQL4 was immunoprecipitated with anti-RECQL4 antibody from U2OS cells, and its ubiquitination was examined with anti-Ub antibody. The U2OS cells were treated with DMSO or a combination of 10 µM RO3306 and 10 µM CDK2i-III for 4 h before IP. e Ser89/Ser251 phosphorylation promotes ubiquitination of RECQL4. HA-tagged ubiquitin and 3xFLAG-tagged WT RECQL4 or RQ4-2A were co-transfected to HEK293T cells, and ubiquitinated proteins were pulled down by HA-IP. Ubiquitinated RECQL4 proteins in the IP product were detected by Western blotting with anti-FLAG antibody. f RQ4-2A showed lower affinity with DDB1 in HEK293T cells. 3xFLAG-tagged WT RECQL4, RQ4-2A, and RQ4-2D were pulled down from HEK293T cells and DDB1 protein was probed by Western blotting analysis. g Knockdown of DDB1 decreases recruitment of RECQL4 to laser-induced DSBs. DDB1 levels in control and DDB1-depleted U2OS cells were determined by Western blotting. DSBs were generated by micro-point laser. Real-time recruitment of GFP-RECQL4 was observed and quantified. Relative intensity of GFP-RECQL4 is shown as mean ± s.e.m. with p-value by Student’s t-test. The number of cells analyzed : for control cells, n = 17; shDDB1, n = 24. Scale bar, 5 µm. h Depletion of CUL4A in U2OS cells caused failure of RECQL4 recruitment at chromatin after IR stress. Subcellular fractionations of control or CUL4A siRNA-treated U2OS cells were prepared and indicated proteins were examined with Western blotting in these fractions
false
- WB
CiteAb
Western blot - Anti-Cullin 4A/CUL-4A antibody (AB72548)
Western Blotting using Anti-Cullin 4A/CUL-4A antibody, ab72548. Publication image from Lu, H. et al., 2017, Nat Commun, 29229926. Legend direct from paper.
DDB1-CUL4A E3 ubiquitin ligase stimulates RECQL4 recruitment to DSBs. a Co-IP analysis for the interaction of RECQL4 with DDB1 and CUL4A in HEK293T cells. DDB1 and CUL4A were pulled down with 3xFLAG-tagged RECQL4 from HEK293T cells. b N-terminal domain of RECQL4 interacts with DDB1 in HEK293T cells. Upper panel shows schematic diagram of 3xFLAG-tagged RECQL4 and the truncated fragments. N-terminal domain (RQ4-NT), helicase domain (RQ4-HE), and C-terminal domain (RQ4-CT) were tagged with both 3xFLAG and SV40 nuclear-location sequence (NLS). c Knockdown of either DDB1 or CUL4A inhibits ubiquitination of RECQL4 in U2OS cells. Endogenous RECQL4 was purified with anti-RECQL4 antibody from denatured U2OS cell lysates and the ubiquitination was then detected with anti-Ub antibody. d Inhibition of CDK1 and CDK2 reduced the ubiquitination of RECQL4 in U2OS cells. RECQL4 was immunoprecipitated with anti-RECQL4 antibody from U2OS cells, and its ubiquitination was examined with anti-Ub antibody. The U2OS cells were treated with DMSO or a combination of 10 µM RO3306 and 10 µM CDK2i-III for 4 h before IP. e Ser89/Ser251 phosphorylation promotes ubiquitination of RECQL4. HA-tagged ubiquitin and 3xFLAG-tagged WT RECQL4 or RQ4-2A were co-transfected to HEK293T cells, and ubiquitinated proteins were pulled down by HA-IP. Ubiquitinated RECQL4 proteins in the IP product were detected by Western blotting with anti-FLAG antibody. f RQ4-2A showed lower affinity with DDB1 in HEK293T cells. 3xFLAG-tagged WT RECQL4, RQ4-2A, and RQ4-2D were pulled down from HEK293T cells and DDB1 protein was probed by Western blotting analysis. g Knockdown of DDB1 decreases recruitment of RECQL4 to laser-induced DSBs. DDB1 levels in control and DDB1-depleted U2OS cells were determined by Western blotting. DSBs were generated by micro-point laser. Real-time recruitment of GFP-RECQL4 was observed and quantified. Relative intensity of GFP-RECQL4 is shown as mean ± s.e.m. with p-value by Student’s t-test. The number of cells analyzed : for control cells, n = 17; shDDB1, n = 24. Scale bar, 5 µm. h Depletion of CUL4A in U2OS cells caused failure of RECQL4 recruitment at chromatin after IR stress. Subcellular fractionations of control or CUL4A siRNA-treated U2OS cells were prepared and indicated proteins were examined with Western blotting in these fractions
false
- WB
CiteAb
Western blot - Anti-Cullin 4A/CUL-4A antibody (AB72548)
Western Blotting using Anti-Cullin 4A/CUL-4A antibody, ab72548. Publication image from Lu, H. et al., 2017, Nat Commun, 29229926. Legend direct from paper.
DDB1-CUL4A E3 ubiquitin ligase stimulates RECQL4 recruitment to DSBs. a Co-IP analysis for the interaction of RECQL4 with DDB1 and CUL4A in HEK293T cells. DDB1 and CUL4A were pulled down with 3xFLAG-tagged RECQL4 from HEK293T cells. b N-terminal domain of RECQL4 interacts with DDB1 in HEK293T cells. Upper panel shows schematic diagram of 3xFLAG-tagged RECQL4 and the truncated fragments. N-terminal domain (RQ4-NT), helicase domain (RQ4-HE), and C-terminal domain (RQ4-CT) were tagged with both 3xFLAG and SV40 nuclear-location sequence (NLS). c Knockdown of either DDB1 or CUL4A inhibits ubiquitination of RECQL4 in U2OS cells. Endogenous RECQL4 was purified with anti-RECQL4 antibody from denatured U2OS cell lysates and the ubiquitination was then detected with anti-Ub antibody. d Inhibition of CDK1 and CDK2 reduced the ubiquitination of RECQL4 in U2OS cells. RECQL4 was immunoprecipitated with anti-RECQL4 antibody from U2OS cells, and its ubiquitination was examined with anti-Ub antibody. The U2OS cells were treated with DMSO or a combination of 10 µM RO3306 and 10 µM CDK2i-III for 4 h before IP. e Ser89/Ser251 phosphorylation promotes ubiquitination of RECQL4. HA-tagged ubiquitin and 3xFLAG-tagged WT RECQL4 or RQ4-2A were co-transfected to HEK293T cells, and ubiquitinated proteins were pulled down by HA-IP. Ubiquitinated RECQL4 proteins in the IP product were detected by Western blotting with anti-FLAG antibody. f RQ4-2A showed lower affinity with DDB1 in HEK293T cells. 3xFLAG-tagged WT RECQL4, RQ4-2A, and RQ4-2D were pulled down from HEK293T cells and DDB1 protein was probed by Western blotting analysis. g Knockdown of DDB1 decreases recruitment of RECQL4 to laser-induced DSBs. DDB1 levels in control and DDB1-depleted U2OS cells were determined by Western blotting. DSBs were generated by micro-point laser. Real-time recruitment of GFP-RECQL4 was observed and quantified. Relative intensity of GFP-RECQL4 is shown as mean ± s.e.m. with p-value by Student’s t-test. The number of cells analyzed : for control cells, n = 17; shDDB1, n = 24. Scale bar, 5 µm. h Depletion of CUL4A in U2OS cells caused failure of RECQL4 recruitment at chromatin after IR stress. Subcellular fractionations of control or CUL4A siRNA-treated U2OS cells were prepared and indicated proteins were examined with Western blotting in these fractions
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (25)
Recent publications for all applications. Explore the full list and refine your search
iScience 27:111399 PubMed39687025
2024
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 14:729-750 PubMed38322326
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:108933 PubMed38318354
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 7: PubMed37940188
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 37:e23373 PubMed37253097
2023
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 9:eade9944 PubMed37027467
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:106468 PubMed37091236
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:974 PubMed35190564
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:2461 PubMed33911083
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 34:108669 PubMed33503431
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com